Food intake regulating hormones in adult craniopharyngioma patients

European Journal of Endocrinology

Volumn 170, Issue 4, 2014, Pages 627-635

  Roemmler Zehrer, J ^a,d   Geigenberger, V ^a   Rmann, S Stö ^a   Losa, M ^c   Crippa, V ^c   Otto, B ^a   Bidlingmaier, M ^a   Dimopoulou, C ^a,b   Stalla, G K ^b   Schopohl, J ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^b MAX PLANCK INSTITUTE OF PSYCHIATRY   (Germany)

^c SAN RAFFAELE HOSPITAL   (Italy)

^d NONE   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLECYSTOKININ; GHRELIN; GLUCOSE; INSULIN; LEPTIN; PEPTIDE YY;

ADULT; AGE; ARTICLE; BODY MASS; CHOLECYSTOKININ BLOOD LEVEL; CONTROLLED STUDY; CRANIOPHARYNGIOMA; DUAL ENERGY X RAY ABSORPTIOMETRY; FAT MASS; FEMALE; FOOD INTAKE; GLUCOSE BLOOD LEVEL; HORMONAL REGULATION; HORMONE RELEASE; HUMAN; INSULIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; METABOLIC DISORDER; NONFUNCTIONING PITUITARY ADENOMA; NUTRITIONAL STATUS; ORAL GLUCOSE TOLERANCE TEST; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SEX DIFFERENCE;

ABSORPTIOMETRY, PHOTON; ADENOMA; ADULT; AGED; APPETITE REGULATION; BLOOD GLUCOSE; BODY FAT DISTRIBUTION; CASE-CONTROL STUDIES; CHOLECYSTOKININ; CRANIOPHARYNGIOMA; FEMALE; GHRELIN; GLUCOSE TOLERANCE TEST; HUMANS; INSULIN; LEPTIN; MALE; MIDDLE AGED; OBESITY; PEPTIDE YY; PITUITARY NEOPLASMS;

EID: 84899471934     PISSN: 08044643     EISSN: 1479683X     Source Type: Journal    
DOI: 10.1530/EJE-13-0832     Document Type: Article

References (44)

1. Muller HL, Gebhardt U, Wessel V, Schroder S, Kolb R, Sorensen N, Maroske J & Hanisch E. First experiences with laparoscopic adjustable gastric banding (LAGB) in the treatment of patients with childhood craniopharyngioma and morbid obesity. Klinische Pädiatrie 2007 219 323-325. (doi:10.1055/s-2007- 985848)
2. Vinchon M, Weill J, Delestret I & Dhellemmes P. Craniopharyngioma and hypothalamic obesity in children. Child's Nervous System 2009 25 347-352. (doi:10.1007/s00381-008-0754-x)
3. Fournier A, Pauli A, Cecile JP, Cousin J & Decherf A. Craniopharyngioma having the appearance of an isolated obesity. Journal des Sciences Médicales de Lille 1968 86 171-175.
4. Crom DB, Smith D, Xiong Z, Onar A, Hudson MM, Merchant TE & Morris EB. Health status in long-term survivors of pediatric craniopharyngiomas. Journal of Neuroscience Nursing 2010 42 323-328 (quiz 329-330). (doi:10.1097/JNN.0b013e3181f8a59d)
5. Lee M & Korner J. Review of physiology, clinical manifestations, and management of hypothalamic obesity in humans. Pituitary 2009 12 87-95. (doi:10.1007/s11102-008-0096-4)
6. Morton GJ, Cummings DE, Baskin DG, Barsh GS & Schwartz MW. Central nervous system control of food intake and body weight. Nature 2006 443 289-295. (doi:10.1038/nature05026)
7. Wynne K, Stanley S, McGowan B & Bloom S. Appetite control. Journal of Endocrinology 2005 184 291-318. (doi:10.1677/joe.1.05866)
8. Roth CL. Hypothalamic obesity in patients with craniopharyngioma: profound changes of several weight regulatory circuits. Frontiers in Endocrinology 2011 2 49. (doi:10.3389/fendo.2011.00049)
9. Lustig RH, Post SR, Srivannaboon K, Rose SR, Danish RK, Burghen GA, Xiong X, Wu S & Merchant TE. Risk factors for the development of obesity in children surviving brain tumors. Journal of Clinical Endocrinology and Metabolism 2003 88 611-616. (doi:10.1210/jc.2002-021180)
10. Hamann A & Matthaei S. Regulation of energy balance by leptin. Experimental and Clinical Endocrinology & Diabetes 1996 104 293-300. (doi:10.1055/s-0029-1211457)
11. Roth C, Wilken B, Hanefeld F, Schroter W & Leonhardt U. Hyperphagia in children with craniopharyngioma is associated with hyperleptinaemia and a failure in the downregulation of appetite. European Journal of Endocrinology 1998 138 89-91. (doi:10.1530/eje.0.1380089)
12. Date Y, Kojima M, Hosoda H, Sawaguchi A, Mondal MS, Suganuma T, Matsukura S, Kangawa K & Nakazato M. Ghrelin, a novel growth hormone-releasing acylated peptide, is synthesized in a distinct endocrine cell type in the gastrointestinal tracts of rats and humans. Endocrinology 2000 141 4255-4261.
13. Shiiya T, Nakazato M, Mizuta M, Date Y, Mondal MS, Tanaka M, Nozoe S, Hosoda H, Kangawa K & Matsukura S. Plasma ghrelin levels in lean and obese humans and the effect of glucose on ghrelin secretion. Journal of Clinical Endocrinology and Metabolism 2002 87 240-244. (doi:10.1210/jcem.87.1.8129)
14. Kanumakala S, Greaves R, Pedreira CC, Donath S, Warne GL, Zacharin MR & Harris M. Fasting ghrelin levels are not elevated in children with hypothalamic obesity. Journal of Clinical Endocrinology and Metabolism 2005 90 2691-2695. (doi:10.1210/jc.2004-2175)
15. Roth CL, Gebhardt U & Muller HL. Appetite-regulating hormone changes in patients with craniopharyngioma. Obesity 2011 19 36-42. (doi:10.1038/oby. 2010.80)
16. Lin S, Boey D & Herzog H. NPY and Y receptors: lessons from transgenic and knockout models. Neuropeptides 2004 38 189-200. (doi:10.1016/j.npep. 2004.05.005)
17. Batterham RL, Heffron H, Kapoor S, Chivers JE, Chandarana K, Herzog H, Le Roux CW, Thomas EL, Bell JD & Withers DJ. Critical role for peptide YY in protein-mediated satiation and body-weight regulation. Cell Metabolism 2006 4 223-233. (doi:10.1016/j.cmet.2006. 08.001)
18. Goldstone AP, Patterson M, Kalingag N, Ghatei MA, Brynes AE, Bloom SR, Grossman AB & Korbonits M. Fasting and postprandial hyperghrelinemia in Prader-Willi syndrome is partially explained by hypoinsulinemia, and is not due to peptide YY3-36 deficiency or seen in hypothalamic obesity due to craniopharyngioma. Journal of Clinical Endocrinology and Metabolism 2005 90 2681-2690. (doi:10.1210/jc.2003-032209)
19. Daousi C, MacFarlane IA, English PJ, Wilding JP, Patterson M, Dovey TM, Halford JC, Ghatei MA & Pinkney JH. Is there a role for ghrelin and peptide-YY in the pathogenesis of obesity in adults with acquired structural hypothalamic damage? Journal of Clinical Endocrinology and Metabolism 2005 90 5025-5030. (doi:10.1210/jc.2004-1874)
20. Woods SC. Gastrointestinal satiety signals I. An overview of gastrointestinal signals that influence food intake. American Journal of Physiology. Gastrointestinal and Liver Physiology 2004 286 G7-G13. (doi:10.1152/ajpgi.00448.2003)
21. Roemmler J, Kuenkler M, Otto B, Arafat AM, Bidlingmaier M & Schopohl J. Influence of long-term growth hormone replacement on leptin and ghrelin in GH deficiency before and after glucose load. Regulatory Peptides 2009 158 40-46. (doi:10.1016/j.regpep. 2009.07.001)
22. Roemmler J, Otto B, Steffin B, Bidlingmaier M & Schopohl J. Serum leptin and ghrelin levels in active and inactive acromegalic patients during an oral glucose tolerance test. Experimental and Clinical Endocrinology & Diabetes 2009 117 135-141. (doi:10.1055/s-2008-1078739)
23. Wu Z, Bidlingmaier M, Liu C, De Souza EB, Tschop M, Morrison KM & Strasburger CJ. Quantification of the soluble leptin receptor in human blood by ligand-mediated immunofunctional assay. Journal of Clinical Endocrinology and Metabolism 2002 87 2931-2939. (doi:10.1210/jcem. 87.6.8610)
24. Riepl RL, Fiedler F, Ernstberger M, Teufel J & Lehnert P. Effect of intraduodenal taurodeoxycholate and L-phenylalanine on pancreatic secretion and on gastroenteropancreatic peptide release in man. European Journal of Medical Research 1996 1 499-505.
25. Doga M, Bonadonna S, Gola M, Mazziotti G & Giustina A. Growth hormone deficiency in the adult. Pituitary 2006 9 305-311. (doi:10.1007/s11102-006- 0410-y)
26. Bougoulia M, Tzotzas T, Efthymiou H, Koliakos G, Konstantinidis T, Triantos A & Krassas GE. Leptin concentrations during oral glucose tolerance test (OGTT) in obese and normal weight women. International Journal of Obesity and Related Metabolic Disorders 1999 23 625-628. (doi:10.1038/sj.ijo.0800891)
27. Saad MF, Damani S, Gingerich RL, Riad-Gabriel MG, Khan A, Boyadjian R, Jinagouda SD, El-Tawil K, Rude RK & Kamdar V. Sexual dimorphism in plasma leptin concentration. Journal of Clinical Endocrinology and Metabolism 1997 82 579-584.
28. Bulow B, Hagmar L, Eskilsson J & Erfurth EM. Hypopituitary females have a high incidence of cardiovascular morbidity and an increased prevalence of cardiovascular risk factors. Journal of Clinical Endocrinology and Metabolism 2000 85 574-584.
29. Makovey J, Naganathan V, Seibel M & Sambrook P. Gender differences in plasma ghrelin and its relations to body composition and bone - an opposite-sex twin study. Clinical Endocrinology 2007 66 530-537.
30. Shaikh MG, Grundy RG & Kirk JM. Hyperleptinaemia rather than fasting hyperinsulinaemia is associated with obesity following hypothalamic damage in children. European Journal of Endocrinology 2008 159 791-797. (doi:10.1530/EJE-08-0533)
31. Guran T, Turan S, Bereket A, Akcay T, Unluguzel G, Bas F, Gunoz H, Saka N, Bundak R, Darendeliler F et al. The role of leptin, soluble leptin receptor, resistin, and insulin secretory dynamics in the pathogenesis of hypothalamic obesity in children. European Journal of Pediatrics 2009 168 1043-1048. (doi:10.1007/s00431-008-0876-x)
32. Roemmler J, Otto B, Arafat AM, Bidlingmaier M & Schopohl J. Influence of pegvisomant on serum ghrelin and leptin levels in acromegalic patients. European Journal of Endocrinology 2010 163 727-734. (doi:10.1530/EJE-10-0344)
33. Lloyd RV, Jin L, Tsumanuma I, Vidal S, Kovacs K, Horvath E, Scheithauer BW, Couce ME & Burguera B. Leptin and leptin receptor in anterior pituitary function. Pituitary 2001 4 33-47.
34. Imbeault P, Doucet E, Mauriege P, St-Pierre S, Couillard C, Almeras N, Despres JP & Tremblay A. Difference in leptin response to a high-fat meal between lean and obese men. Clinical Science 2001 101 359-365. (doi:10.1042/CS20010024)
35. Jenkins AB, Markovic TP, Fleury A & Campbell LV. Carbohydrate intake and short-term regulation of leptin in humans. Diabetologia 1997 40 348-351.
36. Poppitt SD, Leahy FE, Keogh GF, Wang Y, Mulvey TB, Stojkovic M, Chan YK, Choong YS, McArdle BH & Cooper GJ. Effect of high-fat meals and fatty acid saturation on postprandial levels of the hormones ghrelin and leptin in healthy men. European Journal of Clinical Nutrition 2006 60 77-84. (doi:10.1038/sj.ejcn. 1602270)
37. Tschop M, Weyer C, Tataranni PA, Devanarayan V, Ravussin E & Heiman ML. Circulating ghrelin levels are decreased in human obesity. Diabetes 2001 50 707-709. (doi:10.2337/diabetes.50.4.707)
38. Caixas A, Bashore C, Nash W, Pi-Sunyer F & Laferrere B. Insulin, unlike food intake, does not suppress ghrelin in human subjects. Journal of Clinical Endocrinology and Metabolism 2002 87 1902. (doi:10.1210/jcem. 87.4.8538)
39. Freda PU, Reyes CM, Conwell IM, Sundeen RE & Wardlaw SL. Serum ghrelin levels in acromegaly: effects of surgical and long-acting octreotide therapy. Journal of Clinical Endocrinology and Metabolism 2003 88 2037-2044.
40. Haqq AM, Farooqi IS, O'Rahilly S, Stadler DD, Rosenfeld RG, Pratt KL, La Franchi SH & Purnell JQ. Serum ghrelin levels are inversely correlated with body mass index, age, and insulin concentrations in normal children and are markedly increased in Prader-Willi syndrome. Journal of Clinical Endocrinology and Metabolism 2003 88 174-178. (doi:10.1210/jc.2002-021052)
41. Gayoso-Diz P, Otero-Gonzalez A, Rodriguez-Alvarez MX, Gude F, Cadarso-Suarez C, Garcia F & De Francisco A. Insulin resistance index (HOMA-IR) levels in a general adult population: curves percentile by gender and age. The EPIRCE study. Diabetes Research and Clinical Practice 2011 94 146-155. (doi:10.1016/j.diabres.2011. 07.015)
42. Lustig RH, Rose SR, Burghen GA, Velasquez-Mieyer P, Broome DC, Smith K, Li H, Hudson MM, Heideman RL & Kun LE. Hypothalamic obesity caused by cranial insult in children: altered glucose and insulin dynamics and reversal by a somatostatin agonist. Journal of Pediatrics 1999 135 162-168. (doi:10.1016/S0022-3476 (99) 70017-X)
43. Pinto G, Bussieres L, Recasens C, Souberbielle JC, Zerah M & Brauner R. Hormonal factors influencing weight and growth pattern in craniopharyngioma. Hormone Research 2000 53 163-169. (doi:10.1159/000023562)
44. Simoneau-Roy J, O'Gorman C, Pencharz P, Adeli K, Daneman D & Hamilton J. Insulin sensitivity and secretion in children and adolescents with hypothalamic obesity following treatment for craniopharyngioma. Clinical Endocrinology 2010 72 364-370. (doi:10.1111/j.1365-2265.2009.03639.x)